subscribeSubscribe
price-trendAsk Us
EMA gives positive opinion to Fexinidazole as first oral treatment of rhodesiense

EMA gives positive opinion to Fexinidazole as first oral treatment of rhodesiense
GLOBENEWSWIRE
15 Dec 2023
Share Share
Sanofi gets positive EMA opinion for sleeping sickness treatment

Sanofi gets positive EMA opinion for sleeping sickness treatment
REUTERS
15 Dec 2023
Share Share
USFDA approves fexinidazole as first all-oral treatment for sleeping sickness

USFDA approves fexinidazole as first all-oral treatment for sleeping sickness
CONTAGIONLIVE
19 Jul 2021
Share Share
CHMP recommends first oral-only treatment for sleeping sickness

CHMP recommends first oral-only treatment for sleeping sickness
EMA
18 Nov 2018
Share Share
Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18

Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18
EMA
17 Nov 2018
Share Share
Sanofi teams with non-profit on a landmark new drug for sleeping sickness

Sanofi teams with non-profit on a landmark new drug for sleeping sickness
John Carroll ENDPTS
16 Nov 2018
Share Share
Sanofi, DNDi seek EMA review for sleeping sickness drug

Sanofi, DNDi seek EMA review for sleeping sickness drug
Selina McKee PHARMA TIMES
01 Feb 2018
Share Share
Sanofi, DNDi seek EMA review for fexinidazole to treat sleeping sickness

Sanofi, DNDi seek EMA review for fexinidazole to treat sleeping sickness
PHARMABIZ
31 Jan 2018
Share Share